198 filings
Page 5 of 10
424B4
0qtrtd
15 May 19
Prospectus supplement with pricing info
4:47pm
8-K
qpwmyek y0n5
8 May 19
Regulation FD Disclosure
8:50am
8-K
1f0158
30 Apr 19
Evolus Reports First Quarter 2019 Financial Results
4:03pm
DEFA14A
xep2v
29 Apr 19
Additional proxy soliciting materials
5:08pm
DEF 14A
vq1a23vqly1 pkt5
29 Apr 19
Definitive proxy
5:06pm
8-K
2jcmh g08
26 Apr 19
Evolus Receives Positive CHMP Opinion for Nuceiva™ in the European Union
9:01am
EFFECT
rpjaap
16 Apr 19
Notice of effectiveness
12:15am
CORRESP
7261hods
11 Apr 19
Correspondence with SEC
12:00am
S-3/A
olg8 t373kncjr46
10 Apr 19
Shelf registration (amended)
6:33am
CORRESP
2lnieto2
10 Apr 19
Correspondence with SEC
12:00am
UPLOAD
faagb
4 Apr 19
Letter from SEC
12:00am
8-K
sfqswrxwirb 7q5z
1 Apr 19
Evolus Provides Regulatory Update on Nuceiva™ in the European Union
9:05am
S-3
mnxp5r
22 Mar 19
Shelf registration
4:56pm
8-K
ei3hyuum9sgbpjf
18 Mar 19
Evolus Secures $100 Million Senior Debt Facility with Oxford Finance LLC
4:05pm
SC 13G
jwn6w6n
14 Feb 19
Evolus, Inc.
4:28pm
SC 13G
p00c6 3kvcr
12 Feb 19
Evolus, Inc.
9:38am
4
j13jwxabvggxu6f
25 Jan 19
Evolus / Rui Avelar ownership change
8:22pm
4
fpby tyj34bk
25 Jan 19
Evolus / Michael M. Jafar ownership change
8:22pm